Recent advances in the treatment of congenital heart disease.
D000367:Age Factors; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002740:Chlorothiazide / Q000627:therapeutic use; D004039:Diet, Sodium-Restricted / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004077:Digoxin / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006327:Heart Block / Q000601:surgery; D006330:Heart Defects, Congenital / Q000175:diagnosis / Q000628:therapy*; D006333:Heart Failure / Q000188:drug therapy; D006345:Heart Septal Defects, Ventricular / Q000601:surgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009941:Organomercury Compounds / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013771:Tetralogy of Fallot / Q000601:surgery; D014188:Transposition of Great Vessels / Q000601:surgery
D004071:Digitalis Glycosides; D004232:Diuretics; D009941:Organomercury Compounds; D010672:Phenytoin; D004077:Digoxin; D002740:Chlorothiazide; D005665:Furosemide; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D004976:Ethacrynic Acid